Annual Cash & Cash Equivalents
$17.31 M
+$12.12 M+233.33%
31 December 2023
Summary:
Aileron Therapeutics annual cash & cash equivalents is currently $17.31 million, with the most recent change of +$12.12 million (+233.33%) on 31 December 2023. During the last 3 years, it has risen by +$10.27 million (+145.71%). ALRN annual cash & cash equivalents is now -16.42% below its all-time high of $20.71 million, reached on 31 December 2016.ALRN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$17.65 M
-$4.26 M-19.46%
30 September 2024
Summary:
Aileron Therapeutics quarterly cash and cash equivalents is currently $17.65 million, with the most recent change of -$4.26 million (-19.46%) on 30 September 2024. Over the past year, it has increased by +$5.58 million (+46.26%). ALRN quarterly cash and cash equivalents is now -19.46% below its all-time high of $21.92 million, reached on 30 June 2024.ALRN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +233.3% | +46.3% |
| 3 y3 years | +145.7% | +132.2% |
| 5 y5 years | +62.8% | +157.1% |
ALRN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +380.9% | -19.5% | +390.3% |
| 5 y | 5 years | at high | +380.9% | -19.5% | +390.3% |
| alltime | all time | -16.4% | +380.9% | -19.5% | +390.3% |
Aileron Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.65 M(-19.5%) |
| June 2024 | - | $21.92 M(+82.0%) |
| Mar 2024 | - | $12.04 M(-30.4%) |
| Dec 2023 | $17.31 M(+233.3%) | $17.31 M(+43.5%) |
| Sept 2023 | - | $12.07 M(-8.3%) |
| June 2023 | - | $13.17 M(+69.2%) |
| Mar 2023 | - | $7.78 M(+49.8%) |
| Dec 2022 | $5.19 M(+44.3%) | $5.19 M(+7.3%) |
| Sept 2022 | - | $4.84 M(-36.6%) |
| June 2022 | - | $7.63 M(+2.4%) |
| Mar 2022 | - | $7.45 M(+106.9%) |
| Dec 2021 | $3.60 M(-48.9%) | $3.60 M(-52.7%) |
| Sept 2021 | - | $7.60 M(-29.3%) |
| June 2021 | - | $10.75 M(-44.3%) |
| Mar 2021 | - | $19.28 M(+173.7%) |
| Dec 2020 | $7.05 M | $7.05 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $7.85 M(-54.2%) |
| June 2020 | - | $17.12 M(+60.1%) |
| Mar 2020 | - | $10.70 M(+101.4%) |
| Dec 2019 | $5.31 M(-50.1%) | $5.31 M(-22.7%) |
| Sept 2019 | - | $6.87 M(-32.4%) |
| June 2019 | - | $10.16 M(-9.9%) |
| Mar 2019 | - | $11.27 M(+6.0%) |
| Dec 2018 | $10.63 M(-10.4%) | $10.63 M(+37.8%) |
| Sept 2018 | - | $7.72 M(-35.6%) |
| June 2018 | - | $11.98 M(+76.6%) |
| Mar 2018 | - | $6.78 M(-42.8%) |
| Dec 2017 | $11.86 M(-42.7%) | $11.86 M(-11.7%) |
| Sept 2017 | - | $13.43 M(+42.9%) |
| June 2017 | - | $9.40 M(+17.0%) |
| Mar 2017 | - | $8.03 M(-61.2%) |
| Dec 2016 | $20.71 M(+449.8%) | $20.71 M |
| Dec 2015 | $3.77 M | - |
FAQ
- What is Aileron Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aileron Therapeutics?
- What is Aileron Therapeutics annual cash & cash equivalents year-on-year change?
- What is Aileron Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Aileron Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ALRN is $17.31 M
What is the all time high annual cash & cash equivalents for Aileron Therapeutics?
Aileron Therapeutics all-time high annual cash & cash equivalents is $20.71 M
What is Aileron Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ALRN annual cash & cash equivalents has changed by +$12.12 M (+233.33%)
What is Aileron Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALRN is $17.65 M
What is the all time high quarterly cash and cash equivalents for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly cash and cash equivalents is $21.92 M
What is Aileron Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ALRN quarterly cash and cash equivalents has changed by +$5.58 M (+46.26%)